The aim of this study is comparison of hormone suppressor (LD pill) with aspiration in regression of ovarian endometrioma.
In this study womens aged 15-45 who have reffered to Al-Zahra Hospital with ultrasonographic criteria that who have had unilateral endometrioma with size less than or equal to 6 centimeters and test CA 100> 125, randomly placed in one of the following groups. The possibility of malignancy will be excluded.
A) Hormone Suppressor Group: after taking informed consent, patinets daily received one LD pill for three months and at the end, the ultrasound is performed again in terms of cyst regression. Up to 3 months after treatment and cyst regression, the patients will be followed. Questionnaire at the time of inclusion, one, three and six months after treatment, the improvement of clinical symptoms (including: dysmenorrhea, dyspareunia and pelvic pain),regression or recurrence of cyst will be filled.
B) Aspiration Group: after taking informed consent, cyst aspiration under the ultrasound is done by one of the associates of infertility. Three and six months after aspiration, ultrasound is performed again in terms of the re-formation of cysts. Questionnaire at the time of inclusion, one, three and six months after aspiration, in terms of clinical improvement and cyst recurrence and need to re-aspiration will be filled.
After determining inclusion criteria, division of patientswill be done with block randomization and the corresponding software.
The study is not blinded.
primary outcome: cyst regression, improvement of clinical symptoms, including: dysmenorrhea, dyspareunia and pelvic pain.